Lv1
8 积分 2024-12-24 加入
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers
11天前
已完结
Reversibility of immune checkpoint inhibitor-induced hypothyroidism
1个月前
已完结
Report on the First International Workshop on interim-PET scan in lymphoma
2个月前
已完结
T-cell Engagers in Prostate Cancer
3个月前
已完结
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial
5个月前
已完结
FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab as second-line therapy for patients with advanced or metastatic gastroesophageal adenocarcinoma with or without prior docetaxel - results from the phase II RAMIRIS Study of the German Gastric Cancer Study Group at AIO
5个月前
已完结
Mavacamten and Aficamten in Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Trials
6个月前
已关闭
Phase III Evaluation of Treatment Combinations in Three-Arm Trials
6个月前
已完结
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
6个月前
已完结
皖公网安备34019202002308
